16,805
Total Claims
$1.1M
Drug Cost
1,010
Beneficiaries
$1,121
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-26%
Cost per patient vs peers
$1,121 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 15,060 claims · $270K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 386 | $271K |
| Rivaroxaban | 182 | $135K |
| Dapagliflozin Propanediol | 122 | $111K |
| Sacubitril/Valsartan | 123 | $109K |
| Empagliflozin | 67 | $56K |
| Sitagliptin Phos/Metformin Hcl | 32 | $29K |
| Metoprolol Succinate | 1,482 | $24K |
| Evolocumab | 41 | $23K |
| Candesartan Cilexetil | 221 | $20K |
| Ticagrelor | 38 | $20K |
| Sitagliptin Phosphate | 17 | $16K |
| Levothyroxine Sodium | 237 | $15K |
| Candesartan/Hydrochlorothiazid | 97 | $14K |
| Atorvastatin Calcium | 1,300 | $14K |
| Losartan Potassium | 999 | $13K |
Prescribing Profile
102
Unique Drugs
$698K
Patient Profile
75
Avg Age
66%
Female
2.13
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About